60 minutes

Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.

InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR ‘09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Leon MD

PORTON DOWN, England - Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc.

MORE..

Older News

BARCELONA, Spain - InspireMD, Ltd.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy